BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

350 related articles for article (PubMed ID: 25551790)

  • 21. Independent and additive interaction between tumor necrosis factor β +252 polymorphisms and chronic hepatitis B and C virus infection on risk and prognosis of hepatocellular carcinoma: a case-control study.
    Jeng JE; Wu HF; Tsai MF; Tsai HR; Chuang LY; Lin ZY; Hsieh MY; Chen SC; Chuang WL; Wang LY; Yu ML; Dai CY; Tsai JF
    Asian Pac J Cancer Prev; 2014; 15(23):10209-15. PubMed ID: 25556449
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Association between Toll-Like Receptor 3 (TLR3) rs3775290, TLR7 rs179008, TLR9 rs352140 and Chronic HCV.
    Mosaad YM; Metwally SS; Farag RE; Lotfy ZF; AbdelTwab HE
    Immunol Invest; 2019 Apr; 48(3):321-332. PubMed ID: 30321082
    [TBL] [Abstract][Full Text] [Related]  

  • 23. CYP enzyme polymorphisms and susceptibility to HCV-related chronic liver disease and liver cancer.
    Silvestri L; Sonzogni L; De Silvestri A; Gritti C; Foti L; Zavaglia C; Leveri M; Cividini A; Mondelli MU; Civardi E; Silini EM
    Int J Cancer; 2003 Apr; 104(3):310-7. PubMed ID: 12569554
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Chemokine RANTES promoter dimorphisms and hepatocellular carcinoma occurrence in patients with alcoholic or hepatitis C virus-related cirrhosis.
    Charni F; Sutton A; Rufat P; Laguillier C; Mansouri A; Moreau R; Ganne-Carrié N; Trinchet JC; Beaugrand M; Charnaux N; Nahon P
    Cancer Epidemiol Biomarkers Prev; 2011 Jul; 20(7):1439-46. PubMed ID: 21610221
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Role of IFN-ks, IFN-ks related genes and the DEPDC5 gene in Hepatitis B virus-related liver disease.
    Ma N; Zhang X; Yu F; Gao P; Fan Q; Liu L; Liu D
    J Viral Hepat; 2014 Jul; 21(7):e29-38. PubMed ID: 25032264
    [TBL] [Abstract][Full Text] [Related]  

  • 26. IL17A gene polymorphism, serum IL17 and total IgE in Egyptian population with chronic HCV and hepatocellular carcinoma.
    ELBassuoni MA; Abd El Fatah G; Zaghla H
    Immunol Lett; 2015 Dec; 168(2):240-5. PubMed ID: 26367076
    [TBL] [Abstract][Full Text] [Related]  

  • 27. IL28B rs12979860 gene polymorphism in Egyptian patients with chronic liver disease infected with HCV.
    Zekri AR; Salama H; Medhat E; Bahnassy AA; Morsy HM; Lotfy MM; Ahmed R; Darwish T; Marei MS
    Asian Pac J Cancer Prev; 2014; 15(17):7213-8. PubMed ID: 25227816
    [TBL] [Abstract][Full Text] [Related]  

  • 28. CD81 nucleotide mutation in hepatocellular carcinoma and lack of CD81 polymorphism in patients at stages of hepatitis C virus infection.
    Itakura J; Nagayama K; Enomoto N; Sakamoto N; Tazawa J; Izumi N; Marumo F; Sato C
    J Med Virol; 2001 Jan; 63(1):22-8. PubMed ID: 11130883
    [TBL] [Abstract][Full Text] [Related]  

  • 29. IL12 Gene Polymorphism in Association with Hepatocellular Carcinoma in HCV-infected Egyptian Patients.
    Elsayed HM; Nabiel Y; Sheta T
    Immunol Invest; 2017 Feb; 46(2):123-133. PubMed ID: 27819525
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Tumor necrosis factor-alpha -308G/A polymorphism and risk of hepatocellular carcinoma in hepatitis C virus-infected patients.
    Talaat RM; Esmail AA; Elwakil R; Gurgis AA; Nasr MI
    Chin J Cancer; 2012 Jan; 31(1):29-35. PubMed ID: 22200181
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Genetic variations of PD1 and TIM3 are differentially and interactively associated with the development of cirrhosis and HCC in patients with chronic HBV infection.
    Li Z; Li N; Zhu Q; Zhang G; Han Q; Zhang P; Xun M; Wang Y; Zeng X; Yang C; Liu Z
    Infect Genet Evol; 2013 Mar; 14():240-6. PubMed ID: 23291409
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Association between MICA rs2596542 Polymorphism with the Risk of Hepatocellular Carcinoma in Chronic Hepatitis C Patients.
    Marangon CG; de Bitencorte JT; Michita RT; Lunge VR; Dos Santos DC; Álvares-da-Silva MR; Simon D
    Pathol Oncol Res; 2020 Jul; 26(3):1519-1525. PubMed ID: 31471884
    [TBL] [Abstract][Full Text] [Related]  

  • 33. The association of toll-like receptor 4 polymorphism with hepatitis C virus infection in Saudi Arabian patients.
    Al-Qahtani AA; Al-Anazi MR; Al-Zoghaibi F; Abdo AA; Sanai FM; Khan MQ; Albenmousa A; Al-Ashgar HI; Al-Ahdal MN
    Biomed Res Int; 2014; 2014():357062. PubMed ID: 25177689
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Single nucleotide polymorphisms in CXCR1 gene and its association with hepatitis B infected patients in Saudi Arabia.
    Almajhdi FN; Al-Ahdal M; Abdo AA; Sanai FM; Al-Anazi M; Khalaf N; Viswan NA; Al-Ashgar H; Al-Kahtani K; Al-Humaidan H; Al-Swayeh R; Hussain Z; Alarifi S; Al-Okail M; Al-Qahtani A
    Ann Hepatol; 2013; 12(2):220-7. PubMed ID: 23396733
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Vitamin D receptor rs3782905 and vitamin D binding protein rs7041 polymorphisms are associated with hepatocellular carcinoma susceptibility in cirrhotic HCV patients.
    El-Masry AS; Medhat AM; El-Bendary M; Mohamed RH
    BMC Med Genomics; 2023 Dec; 16(1):319. PubMed ID: 38066559
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Polymorphisms of microsomal epoxide hydrolase gene and severity of HCV-related liver disease.
    Sonzogni L; Silvestri L; De Silvestri A; Gritti C; Foti L; Zavaglia C; Bottelli R; Mondelli MU; Civardi E; Silini EM
    Hepatology; 2002 Jul; 36(1):195-201. PubMed ID: 12085365
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Genetic variations in death receptor domain 4 gene and the susceptibility to hepatitis C related hepatocellular carcinoma.
    Zayed SA; Zahran NM; Khorshied MM; Abdel-Aziz AO; Mahmoud O; Morsy SA; Shousha HI; Elbaz TM; Nabeel MM; Harb ARK
    J Med Virol; 2019 Aug; 91(8):1537-1544. PubMed ID: 30945308
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Genome-Wide Association Study Identifies TLL1 Variant Associated With Development of Hepatocellular Carcinoma After Eradication of Hepatitis C Virus Infection.
    Matsuura K; Sawai H; Ikeo K; Ogawa S; Iio E; Isogawa M; Shimada N; Komori A; Toyoda H; Kumada T; Namisaki T; Yoshiji H; Sakamoto N; Nakagawa M; Asahina Y; Kurosaki M; Izumi N; Enomoto N; Kusakabe A; Kajiwara E; Itoh Y; Ide T; Tamori A; Matsubara M; Kawada N; Shirabe K; Tomita E; Honda M; Kaneko S; Nishina S; Suetsugu A; Hiasa Y; Watanabe H; Genda T; Sakaida I; Nishiguchi S; Takaguchi K; Tanaka E; Sugihara J; Shimada M; Kondo Y; Kawai Y; Kojima K; Nagasaki M; Tokunaga K; Tanaka Y;
    Gastroenterology; 2017 May; 152(6):1383-1394. PubMed ID: 28163062
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Genetic Polymorphism of Epidermal Growth Factor rs4444903 Influences Susceptibility to HCV-Related Liver Cirrhosis and Hepatocellular Carcinoma in a Chinese Han Population.
    Zhang S; Qiao K; Trieu C; Huo Z; Dai Q; Du Y; Lu W; Hou W
    Clin Lab; 2017 Apr; 63(4):845-850. PubMed ID: 28397482
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Role of circulating miR-182 and miR-150 as biomarkers for cirrhosis and hepatocellular carcinoma post HCV infection in Egyptian patients.
    Shaheen NMH; Zayed N; Riad NM; Tamim HH; Shahin RMH; Labib DA; ELsheikh SM; Moneim RA; Yosry A; Khalifa RH
    Virus Res; 2018 Aug; 255():77-84. PubMed ID: 30003924
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 18.